Hillsdale Investment Management Inc. Increases Position in UiPath, Inc. $PATH

Hillsdale Investment Management Inc. increased its holdings in UiPath, Inc. (NYSE:PATH) by 413.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 307,700 shares of the company’s stock after acquiring an additional 247,800 shares during the quarter. Hillsdale Investment Management Inc. owned approximately 0.06% of UiPath worth $4,117,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of PATH. D.A. Davidson & CO. increased its position in shares of UiPath by 23.8% in the 3rd quarter. D.A. Davidson & CO. now owns 752,448 shares of the company’s stock worth $10,068,000 after purchasing an additional 144,832 shares during the last quarter. Jackson Creek Investment Advisors LLC acquired a new position in UiPath in the third quarter worth about $1,579,000. AlphaQuest LLC increased its holdings in UiPath by 863.9% in the second quarter. AlphaQuest LLC now owns 42,847 shares of the company’s stock valued at $548,000 after buying an additional 38,402 shares during the last quarter. Russell Investments Group Ltd. raised its stake in UiPath by 7.3% during the second quarter. Russell Investments Group Ltd. now owns 1,445,644 shares of the company’s stock valued at $18,448,000 after buying an additional 98,058 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC raised its stake in UiPath by 115.3% during the third quarter. Campbell & CO Investment Adviser LLC now owns 141,752 shares of the company’s stock valued at $1,897,000 after buying an additional 75,927 shares in the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on PATH. DA Davidson lifted their target price on UiPath from $12.00 to $15.00 and gave the stock a “neutral” rating in a research report on Thursday, December 4th. Truist Financial set a $17.00 price objective on UiPath in a research note on Thursday, December 4th. Royal Bank Of Canada set a $14.00 target price on shares of UiPath in a research note on Wednesday, February 11th. Morgan Stanley increased their target price on shares of UiPath from $15.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 9th. Finally, UBS Group restated a “neutral” rating on shares of UiPath in a research report on Thursday, December 4th. One investment analyst has rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $15.77.

UiPath Stock Performance

Shares of PATH opened at $10.81 on Monday. The firm has a fifty day moving average of $14.56 and a 200-day moving average of $14.00. The company has a market cap of $5.78 billion, a price-to-earnings ratio of 25.73, a price-to-earnings-growth ratio of 1.48 and a beta of 1.07. UiPath, Inc. has a 1 year low of $9.38 and a 1 year high of $19.84.

UiPath (NYSE:PATH) last issued its quarterly earnings data on Wednesday, December 3rd. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.02. The firm had revenue of $411.11 million for the quarter, compared to the consensus estimate of $392.46 million. UiPath had a net margin of 14.79% and a return on equity of 3.73%. UiPath’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same period last year, the firm posted $0.11 EPS. Analysts predict that UiPath, Inc. will post -0.17 EPS for the current year.

Insider Buying and Selling

In other news, CFO Ashim Gupta sold 67,468 shares of the business’s stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $16.10, for a total transaction of $1,086,234.80. Following the completion of the transaction, the chief financial officer directly owned 557,028 shares in the company, valued at approximately $8,968,150.80. The trade was a 10.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Daniel Dines sold 45,000 shares of the firm’s stock in a transaction that occurred on Monday, January 26th. The shares were sold at an average price of $15.01, for a total value of $675,450.00. Following the completion of the sale, the chief executive officer owned 27,893,585 shares in the company, valued at approximately $418,682,710.85. This represents a 0.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 950,048 shares of company stock worth $15,881,744. Corporate insiders own 23.19% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.